A. Liapikou (Athens, Greece), S. De Boer (Auckland, New Zealand), R. Wilson (London, United Kingdom), M. Tamm (Basel, Switzerland)
Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
O. Kilinc, O. Soylar, A. Cilli, A. Sakar, S. Tasbakan, H. Ellidokuz, B. Celenk, C. Cetinkaya, C. Gunduz, A. Sayiner (Izmir, Antalya, Manisa, Turkey)
|  |
Pharmacokinetics and pharmacodynamics of newer fluoroquinolones in patients with lower respiratory tract infections
P. Kontou, K. Chatzika, K. Manika, G. Pitsiou, M. Sionidou, I. Kioumis (Thessaloniki, Greece)
| |
Combination therapy (beta-lactam+macrolide) vs fluoroquinolone monotherapy for the treatment of CAP
C. Triantafyllidis, V. Kapordelis, E.C. Philippidou, G. Papaetis, M. Apostolidou, I. Nikolopoulos, D. Orfanidou, A. Pefanis (Kavala, Athens, Greece)
|  |
Tolerance of nebulised gentamicin in adult bronchiectasis – A single centre study
J. Miller, H. Tedd, S. Syba, H. Groves, A. De Soyza (Newcastle-upon-Tyne, United Kingdom)
| |
An audit of microbiological investigations performed on patients admitted with community acquired pneumonia
J.R. Wilson, J.M. Sloan, C.L. Griffin, M.E.M. Wilkie, J.D. Chalmers, S. Schembri (Dundee, United Kingdom)
| |
Management of community acquired pneumonia (CAP) in a UK district general hospital (DGH)
U. Maqsood, N. Ahmad (Birmingham, Wolverhampton, United Kingdom)
| |
Resistance of problematic gram(-) respiratory pathogens selected from in-patients (Yaroslavl, Russia, 2011)
S. Palyutin, I. Zilber, S. Monakhova, S. Angelova, M. Ershova, G. Abrosimova, E. Poletaeva, A. Petrochenko (Yaroslavl, Russian Federation)
| |
Evaluating flutter device and the active cycle of breathing technique in non-cystic bronchiectasis: The prospective randomised study
G. Altiay, B. Uzmezoglu, N. Sut, H. Tuna, O. N. Hatipoglu (Edirne, Turkey)
| |
RCT of chest physiotherapy versus chest physiotherapy and pulmonary rehabilitation in non cystic fibrosis bronchiectasis
P. Mandal, M. Sidhu, L. Kope, W. Pollock, L. Stevenson, S. MacQuarrie, K. Turnbull, J. Pentland, A. Hill (Edinburgh, United Kingdom)
| |
Unexpectedly high incidence of pneumothorax in patients with pulmonary Mycobacterium avium complex infection
E. Hagiwara, A. Nakazawa, T. Oda, T. Enomoto, T. Baba, R. Nishihira, S. Komatsu, T. Kato, T. Ogura (Yokohama, Japan)
| |
Effects of nebulizer therapy by hypertonic saline, gender and breastfeeding on evolution of acute bronchiolitis
E. Kutsia, T. Ghonghadze, T. Zhorzholiani (Tbilisi, Georgia)
| |
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas
E. Tabernero, R. Alkiza, P. Gil, J. Garros, D. Cantero, J.L. Artola, L. Ramos (Bilbao, Galdakao, Spain)
| |
Changes in the lower airway bacterial community of from adult non-CF bronchiectasis population are significantly associated with exacerbations and the presence of Heamophilus influenza
P. Purcell, S. Cummings, H. Jary, A. De Soyza, J. Perry (Newcastle-upon-Tyne, United Kingdom)
| |
Rapid detection of Mycoplasma pneumoniae IgM antibodies using ImmunoCard Mycoplasma kit compared with complement fixation (CF) tests and clinical application
R. Ueda, J. Okamura, Y. Inoue, T. Mochizuki, T. Sato (Tokyo, Japan)
| |
Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
W. Røysted, O. Simonsen, A. Jenkins, M. Sarjomaa, Y. Tveten, E. Ragnhildstveit, M.V. Svendsen, A. Kanestrøm, H. Waage, J. Ringstad (Skien, Fredrikstad, Bø in Telemark, Norway)
| |
Bronchiectasis in Auckland, New Zealand: Ethnic differences in severity
S. de Boer, W. Fergusson, C. Lewis, M. Wilsher (Auckland, New Zealand)
| |
Pneumonia and Clostridium difficile infection: Hospital acquired infection in a non-ICU department
M. Carrabba, M. Zarantonello, S. Formica, L. Mellace, S. Castaldi, M.D. Cappellini, G. Fabio (Milan, Italy)
| |
Clonal typing of P.aeruginosa strains in non-CF bronchiectasis
M. Drain, L. Wei, D. Gilpin, M. Tunney, D. Kenna, S. Elborn (Belfast, Ireland; London, United Kingdom)
| |
PES in CAP: An acronym to identify "problematic pathogens" in community-acquired pneumonia
E. Prina, M. Ferrer, E. Polverino, C. Cilloniz, J. Mensa, E. Moreno, E. Cuenca, R. Cosentini, A. Torres (Barcelona, Spain; Milan, Italy; Buenos Aires, Argentina)
| |
C-reactive protein in community acquired pneumonia – Correlation with main clinical indices
N. Yanev, P. Nikolova, Y. Ivanov, P. Pavlov, N. Kyuchukov, T. Popova (Pleven, Bulgaria)
| |